Author:
MEASE PHILIP,ARNOLD LESLEY M.,CHOY ERNEST H.,CLAUW DANIEL J.,CROFFORD LESLIE J.,GLASS JENNIFER M.,MARTIN SUSAN A.,MOREA JESSICA,SIMON LEE,STRAND C. VIBEKE,WILLIAMS DAVID A.
Abstract
The objective of the module was to (1) establish a core domain set for fibromyalgia (FM) assessment in clinical trials and practice, (2) review outcome measure performance characteristics, (3) discuss development of a responder index for assessment of FM in clinical trials, (4) review objective markers, (5) review the domain of cognitive dysfunction, and (6) establish a research agenda for outcomes research. Presentations at the module included: (1) Results of univariate and multivariate analysis of 10 FM clinical trials of 4 drugs, mapping key domains identified in previous patient focus group: Delphi exercises and a clinician/researcher Delphi exercise, and breakout discussions to vote on possible essential domains and reliable measures; (2) Updates regarding outcome measure status; (3) Update on objective markers to measure FM disease state; and (4) Review of the issue of cognitive dysfunction (dyscognition) in FM. Consensus was reached as follows: (1) Greater than 70% of OMERACT participants agreed that pain, tenderness, fatigue, patient global, multidimensional function and sleep disturbance domains should be measured in all FM clinical trials; dyscognition and depression should be measured in some trials; and stiffness, anxiety, functional imaging, and cerebrospinal fluid biomarkers were identified as domains of research interest. (2) FM domain outcome measures have generally proven to be reliable, discriminative, and feasible. More sophisticated and comprehensive measures are in development, as is a responder index for FM. (3) Increasing numbers of objective markers are being developed for FM assessment. (4) Cognitive dysfunction assessment by self-assessed and applied outcome measures is being developed. In conclusion, a multidimensional symptom core set is proposed for evaluation of FM in clinical trials. Research on improved measures of single domains and composite measures is ongoing.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference59 articles.
1. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee;Wolfe;Arthritis Rheum,1990
2. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment;Mease;J Rheumatol,2005
3. Staud R . The neurobiology of chronic musculoskeletal pain (including chronic regional pain). In: Wallace DJ Clauw DJ , editors. Fibromyalgia and other central pain syndromes Philadelphia: Lippincott Williams & Wilkins;2005:45â62.
4. An internet survey of 2,596 people with fibromyalgia;Bennett;BMC Musculoskel Disorders,2007
Cited by
194 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献